SCHEMBL20181910

SCHEMBL20181910

CCC(/C(=C/Nc1cc(F)ccc1F)N=N)n1cc(-c2cnc(C(F)(F)F)nc2)c2c(N)ncnc21

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CFTR P13569 13/20 0.38
RET P07949 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
PRKDC P78527 1/20 0.35
EIF2AK3 Q9NZJ5 1/20 0.34
SRC P12931 2/20 0.34
NEK7 Q8TDX7 1/20 0.34
NTRK1 P04629 1/20 0.33
NTRK3 Q16288 1/20 0.33
NTRK2 Q16620 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182294 0.94 CFTR (0.40) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182197 0.92 CFTR (0.43) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182225 0.90 CFTR (0.39) CFTRRETPIK3CDPIK3CAPIK3CB
SCHEMBL20182285 0.90 CFTR (0.41) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182296 0.86 CFTR (0.41) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182235 0.85 EIF2AK3 (0.34) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182291 0.84 NTRK1 (0.38) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20181883 0.84 NTRK1 (0.40) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182255 0.82 SRC (0.39) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182292 0.82 NEK7 (0.37) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed